zadnja posodobitev :
19/11/2024
raziskovalne skupine - Genentech, Inc   pdf  
Združene države Amerike
farmacevtski laboratorij
Genentech, Inc
San Francisco
Viri   Viri   (5)  
1
Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags
Hui A, Yin J, Liu W, Zheng K. (zheng.kai@gene.com)
Int J Pharm Compound - 2021 - ;25,3:246-257
2
Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration.
Kwong Glover Z.W, Gennaro L, Yadav S, Demeule B, Wong P.Y, Sreedhara A. (sreedhaa@gene.com))
J Pharm Sci - 2012 - ; DOI 10.1002 / jps.23403
3
in vitro stability and compatibility of tenecteplase in central venous access devices.
Lentz, Y.K. , Joyce, M., Lam, X. (lentz.yvonne@gene.com)
AAPS Pharm Sci - 2011 - ; 15, 2 : 264-272.
4
In vitro stability and compatibility of tenecteplase in central venous access devices.
Lentz Y.K, Joyce M, Lam X. ()
Hemodial Int - 2011 - ; 15, 2 : 364-272.
5
Stability and activity of alteplase with injectable drugs commonly used in cardiac therapy.
Lam XM, Ward CA, de C du M?e CPR. ()
Am J Health-Syst Pharm - 1995 - ; 52: 1904-1909.

Seznami   molekule študiral   (13)  
Trombolitik Brizgalka Alteplase
rak drog Brizgalka Atezolizumab
Kardiotonik Brizgalka Dobutamine hydrochloride
Kardiotonik Brizgalka Dopamine hydrochloride
Antikoagulant Brizgalka Heparin sodium
Lokalni anestetik Brizgalka Lidocaine hydrochloride
Antiaritmik Brizgalka Metoprolol tartrate
Analgetik Brizgalka Morphine sulfate
Vazodilatator Brizgalka Nitroglycerin
rak drog Brizgalka Pertuzumab
Zaviralec adrenergičnih receptorjev beta Brizgalka Propranolol hydrochloride
Trombolitik Brizgalka Tenecteplase
rak drog Brizgalka Trastuzumab

  Mentions Légales